We are excited to be speaking to Steve Geffon, a highly experienced commercial lead in the eclinical and services market. Steve is the CCO of Science37, an organisation with over 6 years in virtual/decentralised trials. In this podcast, we discuss the possible implications of Covid-19 on this key area in the eclinical space.
Listen to the Podcast below:
